Identification of predictors associated with persisting PAIN in patients with rheumatoid Arthritis (RA) and CONTROLled disease activity
- Conditions
- Rheumatoid Arthritis
- Registration Number
- DRKS00010717
- Lead Sponsor
- AbbVie Deutschland GmbH Co. KG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 647
- Adult patients with a confirmed diagnosis of rheumatoid arthritis according to American College of Rheumatology (ACR) 2010 criteria with active disease (DAS28 = 3.2) plus SJC > 3, CRP above the upper limit of normal or normal CRP value and planned initiation or escalation of anti-inflammatory Treatment
- Disease duration (RA) = 8 years
- Severe Pain (VAS (0-100) = 50))
- Patients with the intellectual capacity to take part in this study
- Adult patients whose signed written informed consent has been obtained
- Patients with a history of chronically manifested pain due to degenerative joint disease, previous surgery, myofascial or ligament dysfunction preceding the flare (active disease inclusion criterion)
- Patients with Fibromyalgia syndrome
- Patients with diabetic neuropathy
- Patients with Psoriasis
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Proportion of patients with severe, persisting pain Visual analogue scale(VAS (0-100) = 50) after week 12 and week 24 despite Disease Activity Score 28 (DAS28) response
- Secondary Outcome Measures
Name Time Method